Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Akebia Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 97 | 2 | 90 | −5 |
| Shares | 57.5M | 400.6K | 52.2M | −4.91M (−8.6%) |
| Value | $20.2M | $141.2K | $16.5M | −$3.55M (−17.7%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Akebia Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 486,568 | $154.0K | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127.0K | 0.02% |
| Marshall Wace, LLP | 314,316 | $101.0K | 0.00% |
| Wipfli Financial Advisors LLC, | 200,000 | $63.0K | 0.00% |
| Public Employees Retirement System of Ohio | 183,979 | $58.0K | 0.00% |
| Charles Schwab Investment Management Inc | 132,370 | $42.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 77,278 | $24.0K | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8.00K | 0.00% |
| HC Advisors, LLC | 10,000 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,721 | $1.00K | 0.00% |
| Halpern Financial, Inc. | 1 | $0 | 0.00% |
Sold out (16)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| AQR Capital Management LLC | 862,168 | $304.0K |
| Voya Investment Management LLC | 301,740 | $107.0K |
| Panagora Asset Management Inc | 250,894 | $89.0K |
| Parallax Volatility Advisers, L.P. | 109,683 | $39.0K |
| Brinker Capital Investments, LLC | 30,196 | $11.0K |
| Squarepoint Ops LLC | 29,471 | $10.0K |
| Teacher Retirement System of Texas | 25,737 | $9.00K |
| Y-Intercept (Hong Kong) Ltd | 25,303 | $9.00K |
| Private Advisor Group, LLC | 20,316 | $7.00K |
| Cubist Systematic Strategies, LLC | 18,295 | $6.00K |
| Legal & General Group Plc | 13,943 | $5.00K |
| Raymond James & Associates | 12,900 | $5.00K |
| Centiva Capital, LP | 13,638 | $5.00K |
| Verition Fund Management LLC | 10,673 | $4.00K |
| New York State Common Retirement Fund | 1,595 | $1.00K |
| Ellevest, Inc. | 443 | $0 |
Not filed for Q3 2022 yet (2)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Icon Wealth Partners, LLC | 400,132 | $141.0K |
| Exane Derivatives | 471 | $166 |